Literature DB >> 7873920

Red cell destruction in cold agglutinin disease.

G Zilow1, M Kirschfink, D Roelcke.   

Abstract

OBJECTIVE: The severity of autoimmune hemolytic anemia (AIHA) caused by cold agglutinins (CAs) is known to differ markedly in chronic CA disease as well as in postinfection cold agglutination. The various cold agglutinin specificities and mechanisms of red cell destruction are described. DATA SOURCES: Original papers and reviews of the German and English literature (Medline research); own results. SELECTION CRITERIA: Original papers and reviews of the recent years on studies of the biochemistry and specificity of CAs and the pathophysiology of AIHA.
RESULTS: A crucial point for the severity of AIHA caused by CAs is the CA-binding capacity to red cells in vivo. This is reflected by the serologic behavior of the actual CA in vitro, represented by its thermal amplitude. Because most CAs are IgM molecules, red cell destruction by CAs is limited to mechanisms initiated by complement (C) activation. In recent years, several CA specificities, in addition to anti-I/i, have been identified on a serological and biochemical basis. CAs of the IgG and rarely of the IgA isotypes have been found.
CONCLUSION: The CA-induced red cell destruction does not only depend on CA titer or its thermal amplitude. The severity of CA-induced AIHA may also depend on CA isotype and/or specificity. Therefore, the complement activation capacity of CAs with a given isotype but different specificities has to be elucidated in further studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7873920     DOI: 10.1159/000223021

Source DB:  PubMed          Journal:  Infusionsther Transfusionsmed        ISSN: 1019-8466


  7 in total

Review 1.  Cold agglutinin disease.

Authors:  Sigbjørn Berentsen
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

2.  [Rheumatoid arthritis and autoimmune hemolysis: B-cell depletion for remission induction in a patient with rheumatoid arthritis and cold agglutinin disease].

Authors:  P Lehmann; W Hartung; B Ehrenstein; J Schölmerich; M Fleck
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

3.  Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma.

Authors:  Ulla Randen; Gunhild Trøen; Anne Tierens; Chloé Steen; Abdirashid Warsame; Klaus Beiske; Geir E Tjønnfjord; Sigbjørn Berentsen; Jan Delabie
Journal:  Haematologica       Date:  2013-10-18       Impact factor: 9.941

4.  Severe acrocyanosis precipitated by cold agglutinin secondary to infection with Mycoplasma pneumoniae in a pediatric patient.

Authors:  Bernadett Mosdósi; Zoltán Nyul; Arnold Nagy; Kata Bölcskei; Tamás Decsi; Zsuzsanna Helyes
Journal:  Croat Med J       Date:  2017-12-31       Impact factor: 1.351

Review 5.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

6.  A Case of Idiopathic Cold Agglutinin Hemolytic Anemia Successfully Treated With Steroids.

Authors:  Asim Haider; Fareeha Alavi; Ayesha Siddiqa; Muhammad Owais; Muzammil Khan
Journal:  Cureus       Date:  2022-03-15

Review 7.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.